Bacolot, Irene .

HRN: 24-93-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/27/2025
06/17/2025
IV
4.5g
Q6
UROSEPSIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: